Combination therapy significantly increases lipid peroxidation in tumor cells, elevates the levels of IFN‐γ, TNF‐β, CD8+ T, and CD4+ T cells, and enhances the anti‐tumor action of immune cells. The gene discussed is CD8A; the disease is neoplasm.